Enhancement of prostate cancer xenograft growth with whole-body radiation and vascular endothelial growth factor

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 923-928

  Gridley, Daila S ^a,b   Andres, Melba L ^a   Slater, James M ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

Cytokines; Prostate cancer; Radiation; VEGF; Xenografts

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CANCER GROWTH; CANCER RESEARCH; CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN CELL; LEUKOCYTE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; SPLEEN CELL; WHOLE BODY RADIATION; XENOGRAFT;

NON-PROGRAMMATIC;

ANIMALS; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; WHOLE-BODY IRRADIATION;

EID: 0030891049     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Wingo PA, Tong T and Bolden S: Cancer statistics, 1995. CA Cancer J 45: 8-30, 1995.
2. Crawford ED, Hisenberger MA, McLeod DC, Spaulding J, Benson R, Dorr FA, Blumenstein BA, Davis MA and Goodman PJ: A control randomized trial of leuprolide with and without fluiamide in prostatic cancer. N Engl J Med 321: 419-424, 1989.
3. Isaacs JT, Schulze H and Coffey DS: Development of androgen resistance in prostment cancer. In: Prostate cancer, part A: Research, endocrine treatment, and histopathology (Murphy G, Khoury S, Kiess R, Chatelair C, and Denis L. eds). New York, Alan R Liss, Inc, 1987, pp 21-31.
4. Kozlowski JM, McEwan R, Keer H, Sensibar J, Sherwood ER, Lee C, Grayback JT, Albini A and Martin GR: Prostate cancer and the invasive phenotype: application of new in vivo and in vitro approaches. In: Tumor progression and metastasis (Fidler IJ and Nicholson G, eds). New York, Alan R Liss, Inc, 1988, pp 189-231.
5. Kozlowski JM. Fidler U, Campbell D, Xu Z-L, Kaighn ME and Hart IR: Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 44: 3522-3529, 1984.
6. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF and Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Investig Urol 17: 16-23, 1979.
7. Sado T, Kamisaku H, Ikurashi Y and Kubo E: immediate and long-term effects of radiation on the immune system of specific-pathogen-free mice. Int J Radial Biol 53: 177-187, 1988.
8. Slater JM, Ngo E and Lau BHS: Effect of therapeutic irradiation on the immune responses. Am J Roentg 726: 313-320, 1976.
9. Aaronson SA: Growth factors and cancer. Science (Washington, DC) 254: 1146-1152, 1991.
10. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS and Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844, 1993.
11. Wan C P, Myung E and Lau BHS: An automated microfluorometric assay for monitoring oxidative burst activity of phagocytes. J Immunol Methods 159: 131 -138, 1993.
12. Duhrsen U and Metcalf D: Model system for leukemic transformation of immortalized hemopoietic cells in irradiated recipient mice. Leukemia 6: 329-333, 1988.
13. Lichtenstein A: Spontaneous tumor lysis mediated by inflammatory neutrophils: dependence upon divalent cations and reduced oxygen intermediates. Blood 67: 657-664, 1986.
14. Flescher E, Gonen P and Keisari Y: Oxidative burst-dependent tumoricidal and tumoristatic activities of paraffin oil-elicited mouse macrophages. J Natl Cancer Inst 72: 1341-1347, 1984.
15. Melder RJ, Brownell AL, Shoup TM, Brownell GL and Jain RK: Imaging of activated natural kilier cells in mice by positron emission tomography: preferential uptake in tumors. Cancer Res 53: 5867-5871, 1993.
16. Narayan K and Cliff WJ: Morphology of irradiated microvasculature: a combined in vivo and electron-microscopic study. Am J Pathol 106: 47-51, 1982.
17. Matzner Y, Cohn M, Hyam E. Razin E, Fuks Z, Buchanan MR, Haas TA, Vlodavsky I and Eldor A: Generation of lipid neutrophil chemoattractant by irradiated bovine aortic endothelial cells. J Immunol 140: 2681-2685, 1988.
18. Colden-Stanfield M. Kalinich JF and Gallin EK: Ionizing radiation increases endothelial and epithelial cell production of influenza virus and leukocyte adherence. J Immunol 153: 5222-5229, 1994.
19. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 7: 27-31, 1995.
20. Folkman J: What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 82: 4-6, 1990.
21. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillim KJ and Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442, 1996.
22. Carmeliet P, Ferreira V, Breier G. Poliefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declereq C, Pawling J, Moons L, Colien D, Risau W and Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439, 1996.
23. Borgstrom P, Hillan KJ, Sriramarao P and Ferrara N: Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 50: 4032-4039, 1996.
24. Goto F, Goto K, Weindel K and Folkman J: Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor On the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Investig 69: 508-517, 1993.
25. Hallahan DE, Haimovitz-Friedman A, Kufe DW, Fuks Z and Weichselbaum RR: The role of cytokines in radiation oncology. In: Important advances in oncology 1993 (DeVita VT, Hellman S and Rosenberg SA, eds), Philadephia, JB Lippincott Co, 1993. pp 71 -80.
26. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN: A perpetual cascade of cytokines postin adiation leads lo pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33: 99-109, 1995.
27. Schott RJ and Morrow LA Growth factors and angiogenesis. Cardiovasc Res 27: 1155-1161, 1993.
28. Lokeshwar BL and Block NL. Isolation of a prostate carcinoma cell proliferation-inhibiting factor from human seminal plasma and its similarity to transforming growth factor β1. Cancer Res 52: 5821-5825, 1992.
29. Iruela-Arispe ML and Sage EH: Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-β1. J Cell Biochem 52: 414-430, 1993.
30. Welch DR, Fabra A and Nakajima M: Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 87: 1486-1490, 1990.
31. Kim IY, Ahn H-J, Zelner DJ, Shaw JW, Sensibar JA, Kim J-H, Kato M and Lee C: Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res 56: 44-48, 1996.